Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001225208-14-015502
Filing Date
2014-06-23
Accepted
2014-06-23 18:09:06
Documents
1
Period of Report
2014-06-20

Document Format Files

Seq Description Document Type Size
1 doc4.html 4  
1 doc4.xml 4 9820
  Complete submission text file 0001225208-14-015502.txt   11270
Mailing Address 755 PAGE MILL ROAD, SUITE A-200 PALO ALTO CA 94304-1005
Business Address
ANDERSON DAVID L (Reporting) CIK: 0000903510 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32979 | Film No.: 14936055

Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Issuer) CIK: 0001183765 (see all company filings)

EIN.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations